$4.99
-0.15-2.92%
Pre-Market: Feb 25, 8:41 AM EDT
Comments
Loading...
Neuphoria Therapeutics Stock Price, Quotes and Forecasts
NEUPNASDAQ
Neuphoria Therapeutics (NEUP) Forecast
NewsEarningsNeuphoria Therapeutics (NEUP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Neuphoria Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NEUP | Benzinga
Explore Neuphoria Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NEUP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neuphoria Therapeutics (NEUP) stock?
You can purchase shares of Neuphoria Therapeutics (NASDAQ:NEUP) through any online brokerage.
Who are Neuphoria Therapeutics (NEUP) competitors?
There are no as such competitors for Neuphoria Therapeutics.
What is the forecast, or price target, for Neuphoria Therapeutics (NEUP) stock?
Neuphoria Therapeutics has a consensus price target of $21.00.
What is the current price for Neuphoria Therapeutics (NEUP)?
The stock price for Neuphoria Therapeutics (NASDAQ: NEUP) is $4.99 last updated February 25, 2025 at 8:41 AM EST.
Does Neuphoria Therapeutics (NEUP) pay a dividend?
There are no upcoming dividends for Neuphoria Therapeutics.
When is Neuphoria Therapeutics (NASDAQ:NEUP) reporting earnings?
Neuphoria Therapeutics’s Q3 earnings are confirmed for Thursday, May 15, 2025.
Is Neuphoria Therapeutics (NEUP) going to split?
There is no upcoming split for Neuphoria Therapeutics.
What sector and industry does Neuphoria Therapeutics (NEUP) operate in?
Neuphoria Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.